These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 17896829)
1. Advances in pneumococcal vaccines: what are the advantages for the elderly? Vila-Córcoles A Drugs Aging; 2007; 24(10):791-800. PubMed ID: 17896829 [TBL] [Abstract][Full Text] [Related]
2. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination. Vila-Córcoles A J Intern Med; 2009 Nov; 266(5):432-44. PubMed ID: 19754854 [TBL] [Abstract][Full Text] [Related]
3. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516 [TBL] [Abstract][Full Text] [Related]
6. Pneumococcal conjugate vaccine for young children. Selman S; Hayes D; Perin LA; Hayes WS Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663 [TBL] [Abstract][Full Text] [Related]
7. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
8. Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice. Vila-Corcoles A; Ochoa-Gondar O Drugs Aging; 2013 May; 30(5):263-76. PubMed ID: 23420119 [TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccination in adults: does it really work? Pitsiou GG; Kioumis IP Respir Med; 2011 Dec; 105(12):1776-83. PubMed ID: 21816596 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients under treatment with chronic haemodialysis: a longitudinal quasi-experimental phase IV study. Vandecasteele SJ; De Bacquer D; Caluwe R; Ombelet S; Van Vlem B Clin Microbiol Infect; 2018 Jan; 24(1):65-71. PubMed ID: 28559003 [TBL] [Abstract][Full Text] [Related]
11. Pneumococcal vaccines. Ho CF; Lin TY Chang Gung Med J; 2005 Nov; 28(11):765-72. PubMed ID: 16422182 [TBL] [Abstract][Full Text] [Related]
12. Advances in pneumococcal vaccines: advantages for infants and children. Bernatoniene J; Finn A Drugs; 2005; 65(2):229-55. PubMed ID: 15631543 [TBL] [Abstract][Full Text] [Related]
13. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). Nuorti JP; Whitney CG; MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868 [TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG; JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal vaccines: an update on current strategies. Bogaert D; Hermans PW; Adrian PV; Rümke HC; de Groot R Vaccine; 2004 Jun; 22(17-18):2209-20. PubMed ID: 15149779 [TBL] [Abstract][Full Text] [Related]
16. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection. Darkes MJ; Plosker GL Paediatr Drugs; 2002; 4(9):609-30. PubMed ID: 12175274 [TBL] [Abstract][Full Text] [Related]
17. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Andrews NJ; Waight PA; George RC; Slack MP; Miller E Vaccine; 2012 Nov; 30(48):6802-8. PubMed ID: 23000122 [TBL] [Abstract][Full Text] [Related]
18. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years. Mitchell R; Trück J; Pollard AJ Expert Opin Biol Ther; 2013 Oct; 13(10):1451-65. PubMed ID: 23889554 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Jackson LA; Gurtman A; Rice K; Pauksens K; Greenberg RN; Jones TR; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B Vaccine; 2013 Aug; 31(35):3585-93. PubMed ID: 23688527 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Jackson LA; Gurtman A; van Cleeff M; Jansen KU; Jayawardene D; Devlin C; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B Vaccine; 2013 Aug; 31(35):3577-84. PubMed ID: 23688526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]